Viewing nowEsotec 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.

MFDS item code 201905343 · Approved 2019.07.29 · Insurance code 057600120
Treatment and prevention of reflux, Zollinger-Ellison syndrome, Helicobacter pylori infection and ulcers, and gastrointestinal disorders caused by anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease and the alleviation of symptoms of erosive reflux esophagitis. It can also be applied as a long-term maintenance therapy to prevent recurrence in patients with esophagitis and is effective for the treatment of symptoms of gastroesophageal reflux disease in patients without esophagitis. It helps in the treatment and prevention of duodenal ulcers and peptic ulcers as part of an antibiotic combination therapy for the eradication of Helicobacter pylori. It is also used for the treatment and prevention of upper gastrointestinal symptoms and gastric and duodenal ulcers caused by the use of nonsteroidal anti-inflammatory drugs. Furthermore, it is effective for the treatment of Zollinger-Ellison syndrome and maintenance therapy to prevent rebleeding of gastric or duodenal ulcers. Overall, it is used for the treatment and prevention of various gastrointestinal-related conditions.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for control of recurring symptoms in patients at high risk of gastric and duodenal ulcers due to administration of nonsteroidal anti-inflammatory drugs. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and heartburn) associated with administration of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. No clinical trials longer than 4 weeks have been conducted. 4) Patients requiring continuous administration of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with administration of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with administration of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for control of recurring symptoms in patients at high risk of gastric and duodenal ulcers due to administration of nonsteroidal anti-inflammatory drugs. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients: No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. 3. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be used in patients who are allergic to certain ingredients or have a history of hypersensitivity to benzimidazoles. Additionally, it is not safe for patients taking certain antibiotics or antiviral medications, as well as nursing mothers or patients with a history of myocardial infarction. This medication contains the dye Yellow No. 4, so patients allergic to this dye should exercise caution. Various side effects such as leukopenia, thrombocytopenia, allergic reactions, headaches, dizziness, and gastrointestinal symptoms may occur while taking this medication, so it is important to consult a physician immediately if any abnormal symptoms occur. Long-term use may result in hypomagnesemia due to decreased magnesium levels, necessitating regular blood tests and monitoring. This medication can increase the risk of bacterial growth in the stomach by inhibiting stomach acid secretion, so patients should inform healthcare professionals if diarrhea or signs of infection persist. Additionally, as this medication can interact with other drugs, patients taking anticoagulants, antibiotics, antiviral drugs, or anticonvulsants must inform healthcare professionals. The safety of this medication has not been thoroughly established during pregnancy or breastfeeding, so it is essential to consult a physician before use. In case of overdose, since there is no specific antidote, appropriate treatment based on symptoms should be administered, and it is important to keep this medication out of reach of children. If this medication needs to be used for a long time, regular check-ups and administering the minimum dose as per the physician's instructions are advisable.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Rielle syndrome, acute generalized exanthematous pustulosis, drug reactions with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal motility disorder, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, hepatic dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, coughing, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, taste loss, parageusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and ensures safe usage.
Light pink round film-coated tablet
Domestic use - 28 tablets/box [(14 tablets/PPT*2)], Export use - 28 tablets/box [(14 tablets/PPT*2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.